Head Office Novartis International AG CH-4002 Basel Switzerland
+41 61 324 11 11 +41 61 324 80 01 Monday - Friday, 8:30 - 17:00, GMT+1 (Central European Time)
More information
Novartis International AG Investor Relations P.O. Box CH-4002 Basel Switzerland
+41 61 324 79 44 investor.relations@novartis.com
Global Media Relations Eric Althoff Basel, Switzerland
+41 61 324 7999 eric.althoff@novartis.com
Report a suspected side effect (also known as an adverse event) related to a Novartis Pharmaceutical drug or a Novartis Vaccine.
Reporting side effects
For questions about investor relations or the share registry, please contact our team. »
Subscribe to e-mail alerts and RSS feeds for Novartis media releases. »
Review key questions and answers about Novartis shares, general finance and investor relations services. »
New investors
Clinical pipeline
Company fact sheet
Management bios
Novartis - Our next phase of growth (0.6 MB)
Turning R&D excellence into commercial success (2.0 MB)
Corporate organizational structure (41 KB)
Stock performance
Novartis announced its results for the first quarter of 2013 on April 24 ›